Causal link between docosahexaenoic acid and osteoporosis: A 2-sample Mendelian randomization study

Area of Science:

• Nutritional Science
• Bone Biology
• Genetic Epidemiology

Background:

• Osteoporosis is a major public health concern characterized by low bone mass and microarchitectural deterioration.
• Docosahexaenoic acid (DHA), an omega-3 fatty acid, plays roles in various physiological processes, but its direct link to osteoporosis is unclear.

Purpose of the Study:

• To investigate the potential causal relationship between blood docosahexaenoic acid levels and osteoporosis.
• To determine if DHA is a risk factor for developing osteoporosis.

Main Methods:

• A 2-sample Mendelian randomization study design was employed.
• Genetic correlation was estimated using chained disequilibrium regression.
• Sensitivity analyses were conducted to ensure the robustness of the findings.

Main Results:

• A significant causal association was found between docosahexaenoic acid and osteoporosis.
• Elevated DHA levels were identified as a risk factor for osteoporosis (OR = 1.099, P = 0.033).
• A 1-SD increase in DHA was associated with a 9.9% increase in osteoporosis risk.

Conclusions:

• Blood docosahexaenoic acid levels are causally linked to osteoporosis.
• DHA is a risk factor for osteoporosis, independent of genetic variation.
• The precise biological mechanisms underlying this causal link require further investigation.